Lung Cancer Trials Ask AI to find trials
Active Not RecruitingPhase 4NCT07220356
Official study title

C-Raven, a Virtual Tobacco Cessation Intervention in Residency Clinics

Study summary

In a residency clinic in Baltimore, the investigators propose to conduct a pilot RCT comparing a) an avatar-delivered computerized intervention (CI) for tobacco cessation augmented with CHW support and navigation to lung cancer screening to b) a waitlist control. With a sample of participants from the residency clinic (N=30), the investigators will collect data on feasibility of recruitment, intervention engagement and completion, and short-term smoking cessation outcomes. Individuals will be assessed at baseline, 1 month, 3 months, and 6 months. The investigators will conduct interviews with a subset of pilot participants to collect qualitative data on intervention acceptability.

Ask AI to explain this study
Start here

Key things to know

Main goalTreatment

This describes the study’s primary purpose.

What is being studiedC-Raven Virtual Tobacco Cessation Counseling and Nicotine Replacement Product

Plus 2 other study approaches.

Who it may be forTobacco Dependence

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jul 6, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Active Not Recruiting

The study is underway but is not accepting new participants.

What kind of study?Phase 4

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Johns Hopkins University

Study sponsor

01
Study overview

What this study is about

Purpose
Treatment
Study type
Interventional
Phase
Phase 4
Sponsor
Johns Hopkins University
Interventions being studied
Behavioral: C-Raven Virtual Tobacco Cessation Counseling; Drug: Nicotine Replacement Product; Other: Community Health Worker; Other: Lung Cancer Screening
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
Supportive or behavioral care→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Age 50 or older
  • Current tobacco use with \>100 cigarettes smoked in the participant's lifetime
  • Considering smoking cessation
  • Planning to remain in local area for at least 6 months
  • English speaking (intervention currently in English only)
Reasons someone may not be able to joinExclusion criteria
  • Contraindication to nicotine replacement therapy
  • Current engagement in formal smoking cessation program
  • Major cognitive or psychiatric impairment
  • Severe hearing impairment
  • Investigator discretion

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Johns Hopkins University School of MedicineBaltimore, Maryland

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 6, 2026. Always confirm current availability with the study team.

View original record ↗